Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Standardized evaluation of TCM drug safety and its safe use in China

  • At: 2007 FIP Congress in Beijing (China)
  • Type: Presentation
  • By: YE, Zuguang (China Academy of Chinese Medical Science, Beijing, China)
  • Abstract:

    Regulatory documents on requirements for TCM drug registration are officially issued, which are divided into 4 levels: Act, Rules, Regulation and Guidance. With the above-mentioned regulations, two-phase and two-level evaluation for TCM drug registration for marketing is established. The requirements for R & D and production of TCM drugs are

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses